Ocumension Therapeutics 5DG.F Stock
Ocumension Therapeutics Price Chart
Ocumension Therapeutics 5DG.F Financial and Trading Overview
| Ocumension Therapeutics stock price | 0.79 EUR |
| Previous Close | 0.93 EUR |
| Open | 0.95 EUR |
| Bid | 0.94 EUR x 0 |
| Ask | 1.02 EUR x 0 |
| Day's Range | 0.94 - 0.95 EUR |
| 52 Week Range | 0.76 - 1.75 EUR |
| Volume | 109 EUR |
| Avg. Volume | 1 EUR |
| Market Cap | 670.54M EUR |
| Beta (5Y Monthly) | 0.951359 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.08 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
5DG.F Valuation Measures
| Enterprise Value | -644344768 EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 4.2183833 |
| Price/Book (mrq) | 0.23552994 |
| Enterprise Value/Revenue | -4.054 |
| Enterprise Value/EBITDA | 1.503 |
Trading Information
Ocumension Therapeutics Stock Price History
| Beta (5Y Monthly) | 0.951359 |
| 52-Week Change | -27.73% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.75 EUR |
| 52 Week Low | 0.76 EUR |
| 50-Day Moving Average | 0.95 EUR |
| 200-Day Moving Average | 1.11 EUR |
5DG.F Share Statistics
| Avg. Volume (3 month) | 1 EUR |
| Avg. Daily Volume (10-Days) | 10 EUR |
| Shares Outstanding | 689.46M |
| Float | 274.15M |
| Short Ratio | N/A |
| % Held by Insiders | 40.33% |
| % Held by Institutions | 32.84% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -253.30% |
| Operating Margin (ttm) | -286.78% |
| Gross Margin | 64.74% |
| EBITDA Margin | -269.73% |
Management Effectiveness
| Return on Assets (ttm) | -8.93% |
| Return on Equity (ttm) | -13.74% |
Income Statement
| Revenue (ttm) | 158.96M EUR |
| Revenue Per Share (ttm) | 0.25 EUR |
| Quarterly Revenue Growth (yoy) | 195.50% |
| Gross Profit (ttm) | 102.92M EUR |
| EBITDA | -428764000 EUR |
| Net Income Avi to Common (ttm) | -402643008 EUR |
| Diluted EPS (ttm) | -0.09 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.31B EUR |
| Total Cash Per Share (mrq) | 1.91 EUR |
| Total Debt (mrq) | 29.58M EUR |
| Total Debt/Equity (mrq) | 1.08 EUR |
| Current Ratio (mrq) | 5.876 |
| Book Value Per Share (mrq) | 3.991 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -200656992 EUR |
| Levered Free Cash Flow (ttm) | -404455008 EUR |
Profile of Ocumension Therapeutics
| Country | Germany |
| State | N/A |
| City | Suzhou |
| Address | No. 1858 Yinzhongnan Road |
| ZIP | N/A |
| Phone | N/A |
| Website | https://www.ocumension.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 398 |
Ocumension Therapeutics, together with its subsidiaries, operates as an ophthalmic pharmaceutical platform company in the People's Republic of China. It discovers, develops, and commercializes therapies for ophthalmic patients. The company offers drugs for the treatment of blepharitis, infective and allergic conjunctivitis, dry eye, glaucoma and ocular hypertension, postoperative inflammation, choroidal neovascularization, bacterial conjunctivitis, uveitis, retinitis pigmentosa, acute glaucoma, age-related macular degeneration, cornea graft rejection, myopia, and optic neuritis. It had various drug assets in its portfolio. The company was founded in 2017 and is headquartered in Suzhou, the People's Republic of China.
Q&A For Ocumension Therapeutics Stock
What is a current 5DG.F stock price?
Ocumension Therapeutics 5DG.F stock price today per share is 0.79 EUR.
How to purchase Ocumension Therapeutics stock?
You can buy 5DG.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Ocumension Therapeutics?
The stock symbol or ticker of Ocumension Therapeutics is 5DG.F.
Which industry does the Ocumension Therapeutics company belong to?
The Ocumension Therapeutics industry is Biotechnology.
How many shares does Ocumension Therapeutics have in circulation?
The max supply of Ocumension Therapeutics shares is 712.75M.
What is Ocumension Therapeutics Price to Earnings Ratio (PE Ratio)?
Ocumension Therapeutics PE Ratio is now.
What was Ocumension Therapeutics earnings per share over the trailing 12 months (TTM)?
Ocumension Therapeutics EPS is -0.08 EUR over the trailing 12 months.
Which sector does the Ocumension Therapeutics company belong to?
The Ocumension Therapeutics sector is Healthcare.